Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Financial Planning > Tax Planning > Tax Loss Harvesting

New test predicts Alzheimer's

Your article was successfully shared with the contacts you provided.

A study published in Archives of Neurology reports that a new spinal fluid test can predict with 100 percent accuracy those patients suffering memory loss who will eventually develop Alzheimer’s disease.

This breakthrough offers new hope to victims of the disease and their families, who heretofore could only know for sure that Alzheimer’s was the cause of their suffering after an autopsy was performed.

Today, experts believe Alzheimer’s begins years before the first symptoms appear; by that point, the brain has already been damaged. This new test will identify those in the earliest stages of the disease so that the efficacy of new drugs that could slow or stop the disease may be studied.

The new test joins PET scans, already in use, which reveal the amyloid plaques characteristic of the disease. The belief is that in time new medications will be developed that will halt or perhaps even reverse the agonizing disease, which destroys a patient’s ability to reason and remember.


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.